Since GSK-3β has a crucial role in metabolism, insulin signaling, protein regulation, and inflammation, GSK-3β inhibition is considered an attractive target for therapeutic intervention in metabolic and neurodegenerative diseases [23]. The gene discussed is INS; the disease is neurodegenerative disease.